Recent studies have found a correlation between elevated serum levels of GGT and various digestive tumors, including pancreatic head carcinoma (Lyu et al., 2021), colorectal carcinoma (Gong et al., 2021), and gallbladder carcinoma (Su et al., 2021). The gene discussed is GGT1; the disease is colorectal carcinoma.